ClinVar Miner

Submissions for variant NM_001113378.2(FANCI):c.2568_2569del (p.Gly857fs)

gnomAD frequency: 0.00001  dbSNP: rs1385885533
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001205465 SCV001376725 pathogenic Fanconi anemia 2023-12-27 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Gly857Alafs*6) in the FANCI gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCI are known to be pathogenic (PMID: 17452773, 17460694). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FANCI-related conditions. ClinVar contains an entry for this variant (Variation ID: 936631). For these reasons, this variant has been classified as Pathogenic.
Fulgent Genetics, Fulgent Genetics RCV002497697 SCV002810429 likely pathogenic Fanconi anemia complementation group I 2021-07-23 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001205465 SCV003922780 likely pathogenic Fanconi anemia 2023-03-30 criteria provided, single submitter clinical testing Variant summary: FANCI c.2568_2569delAG (p.Gly857AlafsX6) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 6.3e-06 in 158550 control chromosomes. To our knowledge, no occurrence of c.2568_2569delAG in individuals affected with Fanconi Anemia and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Baylor Genetics RCV002497697 SCV004197236 likely pathogenic Fanconi anemia complementation group I 2022-08-18 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.